激活DNA条形码的脂质纳米颗粒的跟踪:药物负载依赖的生物分布和瘤微环境向
Letao Xu1,2, Rui Chen1, Xing Wang1
1School of Chemical Engineering, Faculty of Science, Engineering and Technology, The University of Adelaide, Adelaide, SA, 5005, Australia.
Advanced healthcare materials
|June 26, 2025
概括
高药载脂纳米颗粒 (LNP) 在脏中积累,并被瘤巨细胞吸收,与低负载LNP不同. 这项研究优化了用于癌症治疗的LNP药物输送.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 药理学 药理学 是一个学科.
背景情况:
- 脂质纳米粒子 (LNP) 是关键的药物输送载体,但药物载荷 (DL) 对它们行为的影响尚不清楚.
- 优化DL对于LNP在癌症治疗中的有效性和安全性至关重要,减少纳米材料暴露.
- 了解DL的影响对于推进基于LNP的癌症治疗至关重要.
研究的目的:
- 研究脂质纳米粒子 (LNP) 中药物负载 (DL) 的变化如何影响其体内生物分布和细胞吸收.
- 建立一种DNA条形码方法,用于高灵敏度跟踪具有不同DL的LNP.
- 在瘤微环境 (TME) 内的向癌症治疗LNP的合理设计指导.
主要方法:
- 使用序列纳米沉制造低 (1%),中 (16%),高 (26%) 药物负载的DNA条形编码LNP.
- 向瘤携带的小鼠静脉注射聚合的,条形码的LNP.
- 通过qPCR量化LNP生物分布,并分析TME中的细胞吸收.
主要成果:
- 高DLLNP显示脏积累优先,而低DLLNP在肝脏中积累更多,表明清除速度更快.
- 观察到,TME内的瘤相关巨细胞对高DLLNP的吸收增加.
- 该DNA条形码平台使得灵敏的,同时监测LNP行为,减少动物的使用和变化.
结论:
- 药物负载显著影响LNP生物分布和与瘤相关的巨细胞吸收.
- 优化的DL LNP显示出在TME内有针对性交付的潜力.
- DNA条形码为LNP行为分析提供了强大的工具,有助于开发先进的癌症疗法.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


